Pattern of treatment, started or increased for NP event, between patients with and without NP events attributed to SLE with the Italian algorithm
| . | Diffuse central . | Focal central . | Peripheral . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall, N = 217 . | Not AA, N = 167 . | AA, N = 50 . | P-valueb . | Overall, N = 79 . | Not AA, N = 15 . | AA, N = 64 . | P-valueb . | Overall, N = 53 . | Not AA, N = 12 . | AA N = 41 . | P-valueb . | |
| ISsa | 24.9 | 16.8 (11.4, 23.3) | 52.0 (37.4, 66.3) | <0.001 | 48.1 | 20.0 (4.3, 48.1) | 54.7 (41.7, 67.2) | 0.02 | 45.3 | 25.0 (5.5, 57.2) | 51.2 (35.1, 67.1) | 0.2 |
| Antiaggregant | 7.4 | 5.4 (2.49, 10,0) | 14.0 (5.8, 26.7) | 0.06 | 39.2 | 40.0 (16.3, 67.7) | 39.1 (27.1, 52.1) | >0.9 | 15.1 | 0.0 | 19.5 (8.8, 34.9) | 0.2 |
| Anticoagulanta | 1.4 | 1.8 (0.37, 5.2) | 0.0 | >0.9 | 16.5 | 13.3 (1.7, 40.5) | 17.2 (8.9, 28.7) | >0.9 | 0.0 | 0.0 | 0.0 | — |
| HCQa | 11.5 | 7.2 (3.8, 12.2) | 26.0 (14.6, 40.3) | <0.001 | 32.9 | 13.3 (1.7, 40.5) | 37.5 (25.7, 50.5) | 0.1 | 18.9 | 8.3 (0.2, 38.5) | 22.0 (10.6, 37.6) | 0.4 |
| GCsa | 31.8 | 21.6 (15.6, 28.6) | 66.0 (51.2, 78.8) | <0.001 | 46.8 | 13.3 (1.7, 40.5) | 54.7 (41.7, 67.2) | 0.004 | 50.9 | 25.0 (5.5, 57.2) | 58.5 (42.1, 73.7) | 0.054 |
| . | Diffuse central . | Focal central . | Peripheral . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall, N = 217 . | Not AA, N = 167 . | AA, N = 50 . | P-valueb . | Overall, N = 79 . | Not AA, N = 15 . | AA, N = 64 . | P-valueb . | Overall, N = 53 . | Not AA, N = 12 . | AA N = 41 . | P-valueb . | |
| ISsa | 24.9 | 16.8 (11.4, 23.3) | 52.0 (37.4, 66.3) | <0.001 | 48.1 | 20.0 (4.3, 48.1) | 54.7 (41.7, 67.2) | 0.02 | 45.3 | 25.0 (5.5, 57.2) | 51.2 (35.1, 67.1) | 0.2 |
| Antiaggregant | 7.4 | 5.4 (2.49, 10,0) | 14.0 (5.8, 26.7) | 0.06 | 39.2 | 40.0 (16.3, 67.7) | 39.1 (27.1, 52.1) | >0.9 | 15.1 | 0.0 | 19.5 (8.8, 34.9) | 0.2 |
| Anticoagulanta | 1.4 | 1.8 (0.37, 5.2) | 0.0 | >0.9 | 16.5 | 13.3 (1.7, 40.5) | 17.2 (8.9, 28.7) | >0.9 | 0.0 | 0.0 | 0.0 | — |
| HCQa | 11.5 | 7.2 (3.8, 12.2) | 26.0 (14.6, 40.3) | <0.001 | 32.9 | 13.3 (1.7, 40.5) | 37.5 (25.7, 50.5) | 0.1 | 18.9 | 8.3 (0.2, 38.5) | 22.0 (10.6, 37.6) | 0.4 |
| GCsa | 31.8 | 21.6 (15.6, 28.6) | 66.0 (51.2, 78.8) | <0.001 | 46.8 | 13.3 (1.7, 40.5) | 54.7 (41.7, 67.2) | 0.004 | 50.9 | 25.0 (5.5, 57.2) | 58.5 (42.1, 73.7) | 0.054 |
Pattern of treatment, started or increased for NP event, between patients with and without NP events attributed to SLE with the Italian algorithm
| . | Diffuse central . | Focal central . | Peripheral . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall, N = 217 . | Not AA, N = 167 . | AA, N = 50 . | P-valueb . | Overall, N = 79 . | Not AA, N = 15 . | AA, N = 64 . | P-valueb . | Overall, N = 53 . | Not AA, N = 12 . | AA N = 41 . | P-valueb . | |
| ISsa | 24.9 | 16.8 (11.4, 23.3) | 52.0 (37.4, 66.3) | <0.001 | 48.1 | 20.0 (4.3, 48.1) | 54.7 (41.7, 67.2) | 0.02 | 45.3 | 25.0 (5.5, 57.2) | 51.2 (35.1, 67.1) | 0.2 |
| Antiaggregant | 7.4 | 5.4 (2.49, 10,0) | 14.0 (5.8, 26.7) | 0.06 | 39.2 | 40.0 (16.3, 67.7) | 39.1 (27.1, 52.1) | >0.9 | 15.1 | 0.0 | 19.5 (8.8, 34.9) | 0.2 |
| Anticoagulanta | 1.4 | 1.8 (0.37, 5.2) | 0.0 | >0.9 | 16.5 | 13.3 (1.7, 40.5) | 17.2 (8.9, 28.7) | >0.9 | 0.0 | 0.0 | 0.0 | — |
| HCQa | 11.5 | 7.2 (3.8, 12.2) | 26.0 (14.6, 40.3) | <0.001 | 32.9 | 13.3 (1.7, 40.5) | 37.5 (25.7, 50.5) | 0.1 | 18.9 | 8.3 (0.2, 38.5) | 22.0 (10.6, 37.6) | 0.4 |
| GCsa | 31.8 | 21.6 (15.6, 28.6) | 66.0 (51.2, 78.8) | <0.001 | 46.8 | 13.3 (1.7, 40.5) | 54.7 (41.7, 67.2) | 0.004 | 50.9 | 25.0 (5.5, 57.2) | 58.5 (42.1, 73.7) | 0.054 |
| . | Diffuse central . | Focal central . | Peripheral . | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall, N = 217 . | Not AA, N = 167 . | AA, N = 50 . | P-valueb . | Overall, N = 79 . | Not AA, N = 15 . | AA, N = 64 . | P-valueb . | Overall, N = 53 . | Not AA, N = 12 . | AA N = 41 . | P-valueb . | |
| ISsa | 24.9 | 16.8 (11.4, 23.3) | 52.0 (37.4, 66.3) | <0.001 | 48.1 | 20.0 (4.3, 48.1) | 54.7 (41.7, 67.2) | 0.02 | 45.3 | 25.0 (5.5, 57.2) | 51.2 (35.1, 67.1) | 0.2 |
| Antiaggregant | 7.4 | 5.4 (2.49, 10,0) | 14.0 (5.8, 26.7) | 0.06 | 39.2 | 40.0 (16.3, 67.7) | 39.1 (27.1, 52.1) | >0.9 | 15.1 | 0.0 | 19.5 (8.8, 34.9) | 0.2 |
| Anticoagulanta | 1.4 | 1.8 (0.37, 5.2) | 0.0 | >0.9 | 16.5 | 13.3 (1.7, 40.5) | 17.2 (8.9, 28.7) | >0.9 | 0.0 | 0.0 | 0.0 | — |
| HCQa | 11.5 | 7.2 (3.8, 12.2) | 26.0 (14.6, 40.3) | <0.001 | 32.9 | 13.3 (1.7, 40.5) | 37.5 (25.7, 50.5) | 0.1 | 18.9 | 8.3 (0.2, 38.5) | 22.0 (10.6, 37.6) | 0.4 |
| GCsa | 31.8 | 21.6 (15.6, 28.6) | 66.0 (51.2, 78.8) | <0.001 | 46.8 | 13.3 (1.7, 40.5) | 54.7 (41.7, 67.2) | 0.004 | 50.9 | 25.0 (5.5, 57.2) | 58.5 (42.1, 73.7) | 0.054 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
